Glenmark Pharmaceuticals Ltd on Wednesday said its US arm has launched the generic version of Clindamycin Phosphate foam, an.

Glenmark Pharmaceuticals's US arm has launched a generic version of Clindamycin Phosphate foam, an antibiotic acne treatment.

Topical clindamycin is a first-line treatment for a severe type of acne that happens when bacteria clog pores and triggers ...

Glenmark Pharma ceuticals Inc., USA introduces clindamycin phosphate foam, 1%: Our Bureau, Mumbai Wednesday, February 12, 2025, 12:30 Hrs [IST] Glenmark Pharmaceuticals Inc., USA ...

According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, 1% market achieved annual sales of approximately $5.8 million ...

This new product is bioequivalent and therapeutically equivalent to the reference-listed drug, Evoclin Foam, 1%, manufactured ...

To assess lolamicin’s effect on the gut microbiome, the researchers treated healthy mice with lolamicin or conventional antibiotics and sequenced the DNA from their feces. Clindamycin and amoxycillin ...

Clindamycin (as phosphate) 1%; lotion; gel. Clindamycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome. Clindamycin is predominantly ...

Antibiotic regimens prospectively studied ... For the reasons noted earlier, we recommend metronidazole or clindamycin in combination with ceftriaxone as our regimen of choice.

Glenmark Pharmaceuticals has announced the launch of Clindamycin Phosphate Foam, which is a bioequivalent and therapeutically equivalent to the reference listed drug, Evoclin Foam of Mylan ...